Literature DB >> 24171916

Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.

Tatiana Nwankwo1, Sung Sug Yoon, Vicki Burt, Quiping Gu.   

Abstract

The overall prevalence of hypertension has not changed appreciably since 2009-2010. The age-adjusted prevalence of hypertension among U.S. adults was 29.1% in 2011-2012. Among adults with hypertension in 2011-2012, 82.8% were aware of their hypertension, 75.7% were currently taking medication to lower their blood pressure, and 51.9% had their blood pressure controlled to less than 140/90 mm Hg. Men and women had similar prevalence and awareness of hypertension, but more women than men were treating their hypertension and had it under control. Young adults aged 18-39 continued to have lower awareness, treatment, and control of their hypertension compared with older adults. Hypertension prevalence was still highest among non-Hispanic black adults. However, awareness, treatment, and control of hypertension were similar among non-Hispanic black, non-Hispanic white, and Hispanic adults. Non-Hispanic Asian adults had a lower prevalence of awareness than the other race and Hispanic origin groups, and lower treatment than non-Hispanic white and non-Hispanic black adults. However, hypertension control was similar among non-Hispanic Asian adults and the other race and Hispanic origin groups. Hypertension is a common and manageable chronic condition. Based on recent national data from 2011-2012, treatment of hypertension exceeded the Healthy People 2020 target goal of 69.5%. However, the control of hypertension has neither met the goal of the Healthy People 2020 (61.2% by 2020) nor the Million Hearts Initiative (65% by 2017). These results provide evidence for continued efforts to improve the management of hypertension in order to attain these goals. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24171916

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  262 in total

Review 1.  Tolerability of Antihypertensive Medications in Older Adults.

Authors:  Thiruvinvamalai S Dharmarajan; Lekshmi Dharmarajan
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

Review 2.  Recognition and Management of Hypertension in Older Persons: Focus on African Americans.

Authors:  Carolyn H Still; Keith C Ferdinand; Gbenga Ogedegbe; Jackson T Wright
Journal:  J Am Geriatr Soc       Date:  2015-10       Impact factor: 5.562

Review 3.  The toll of the gridiron: damage-associated molecular patterns and hypertension in American football.

Authors:  Cameron G McCarthy; R Clinton Webb
Journal:  FASEB J       Date:  2015-08-27       Impact factor: 5.191

4.  Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy.

Authors:  Rodrigo B Interiano; Noel Delos Santos; Sujuan Huang; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Daniel M Green; Andrew M Davidoff
Journal:  Cancer       Date:  2015-04-01       Impact factor: 6.860

5.  Racial and Ethnic Disparities in Diagnosis of Chronic Medical Conditions in the USA.

Authors:  Eun Ji Kim; Taekyu Kim; Joseph Conigliaro; Jane M Liebschutz; Michael K Paasche-Orlow; Amresh D Hanchate
Journal:  J Gen Intern Med       Date:  2018-05-07       Impact factor: 5.128

6.  The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease.

Authors:  Pelbreton C Balfour; Carlos J Rodriguez; Keith C Ferdinand
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-04

7.  Evaluation of an Electronic Clinical Decision Support Tool for Incident Elevated BP in Adolescents.

Authors:  Elyse Olshen Kharbanda; Stephen E Asche; Alan Sinaiko; James D Nordin; Heidi L Ekstrom; Patricia Fontaine; Steven P Dehmer; Nancy E Sherwood; Patrick J O'Connor
Journal:  Acad Pediatr       Date:  2017-07-16       Impact factor: 3.107

8.  Blood pressure normalization via pharmacotherapy improves cutaneous microvascular function through NO-dependent and NO-independent mechanisms.

Authors:  Daniel H Craighead; Caroline J Smith; Lacy M Alexander
Journal:  Microcirculation       Date:  2017-10       Impact factor: 2.628

Review 9.  Hypertension Treatment in Blacks: Discussion of the U.S. Clinical Practice Guidelines.

Authors:  Stephen K Williams; Joseph Ravenell; Sara Seyedali; Sam Nayef; Gbenga Ogedegbe
Journal:  Prog Cardiovasc Dis       Date:  2016-09-29       Impact factor: 8.194

Review 10.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.